ADHD in the News 2021-01-21
ADHD Treatment Change Impacts Remote Patient Monitoring
A pilot study assessing the use of telemedicine in patient-reported responses to adult ADHD treatment showed a notable sensitivity to the impact of therapy changes on symptoms and patient functioning...The Shire and Takeda-supported trial, presented by author Craig Surman, MD, included 90-plus patients aged 18-80 who self-identified a taking stimulant therapy for ADHD.
Surveys Show Remote Behavioral Parent Training for ADHD is Acceptable Option
Virtual Behavioral Parent Training (BPT) appears to be an acceptable alternative for parents of children with ADHD, according to findings presented at the 2021 American Professional Society of ADHD and Related Disorders (APSARD) Annual Virtual Meeting.
Novel SMS Strategy May Help Increase Stimulant Adherence in Adults with ADHD
Although evidence demonstrates that stimulants offer protective effects for adults with ADHD, there is nonetheless an issue with non-adherence among the patient population. It is estimated that up to 87% of these patients fail to adhere to stimulant treatment...A team led by Ronna Fried, EdD, Director of Paradigm Development, Massachusetts General Hospital, demonstrated that a text messaging-based (SMS) intervention system significantly improved patient adherence to stimulant treatments.
Sleep Regularity, Timing Could Influence ADHD Symptoms in Teens
Timing and regularity of sleep could be a crucial factor in symptoms and social functioning associated with ADHD, according to new research presented at The American Professional Society of ADHD and Related Disorders (APSARD) 2021 Annual Conference this weekend.
Andrew J. Cutler, MD: The Value of Delayed Release ADHD Treatments
In an interview with HCPLive®, Andrew J. Cutler, MD, Clinical Professor of Psychiatry at SUNY Upstate Medical University, discussed the value of extended release medication and how it can aid patients in improving their quality of life. (video)
David W. Goodman, MD: Silver Linings in ADHD
In an interview with HCPLive®, David W. Goodman, MD, FAPA, assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, said despite the obvious challenges the pandemic has caused, he is hopeful some ADHD were able to adapt to a new routine that did not exacerbate some of the symptoms associated with the disorder. (video)
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
In an interview with HCPLive®, David W. Goodman, MD, FAPA, assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, explained how ADHD patients may have struggled greatly in the last 10 months and how that struggle could have both short- and long-term issues. (video)
ADHD Coaching an Emerging Tool for Patients
In an interview with HCPLive®, Elizabeth Ahmann, Research Director of the Springer Institute and Micah Saviet, Director of the Springer Institute, explained how the results of the focus group show what the role of ADHD might be moving forward. (video)
Postnatal Smoke Exposure Likely Significant Risk Factor for ADHD in Children
Secondhand exposure to smoke may have more of an impact on a child’s hyperactivity than prenatal exposure, according to findings presented at the 2021 American Professional Society of ADHD and Related Disorders (APSARD) Annual Virtual Meeting. The study, led by Julia Schecter, PhD, Duke University School of Medicine, performed various measures to explore the relationship between postnatal exposure and child behavior.
Comorbidities Related to Pediatric ADHD May Be Characterized Using CBCL
The Child Behavior Checklist may provide invaluable information to clinicians regarding the type and severity of comorbid psychopathologies...A team led by Joseph Biederman, MD, Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, evaluated whether or not the CBCL would be useful in characterizing such comorbid psychopathy.
Adulthood Alcohol Problems Linked to Adolescent ADHD
In new data presented at The American Professional Society of ADHD and Related Disorders (APSARD) 2021 Annual Conference this weekend, a team of US-based investigators report an evolved understanding of developmental-based alcohol problem risks among young patients with ADHD—one which may better inform preventive intervention that would limit alcoholism and other substance abuse into such a patients’ 30s and beyond.